BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25869031)

  • 1. Sense, missense, and nonsense: a novel mechanism of premature termination codon (PTC) mutation in a severe von Willebrand disease (VWD) patient.
    Kasatkar P; Kulkarni B; Ghosh K; Shetty S
    Ann Hematol; 2015 Aug; 94(8):1409-10. PubMed ID: 25869031
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene symbol: VWF. Disease: Von Willebrand disease?
    Mueller OT
    Hum Genet; 2008 Jun; 123(5):539. PubMed ID: 20960608
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
    Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
    Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premature termination codon mutations in the von Willebrand factor gene are associated with allele-specific and position-dependent mRNA decay.
    Platè M; Duga S; Baronciani L; La Marca S; Rubini V; Mannucci PM; Federici AB; Asselta R
    Haematologica; 2010 Jan; 95(1):172-4. PubMed ID: 19773258
    [No Abstract]   [Full Text] [Related]  

  • 5. A 12.3-kb Duplication Within the
    Lehner S; Ekhlasi-Hundrieser M; Detering C; Allerkamp H; Pfarrer C; von Depka Prondzinski M
    G3 (Bethesda); 2018 Feb; 8(2):577-585. PubMed ID: 29208651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal recessive von Willebrand disease associated with compound heterozygosity for a novel nonsense mutation (2908 del C) and the missense mutation C2362F: definite evidence for the non-penetrance of the C2362F mutation.
    Castaman G; Bertoncello K; Bernardi M; Eikenboom JC; Budde U; Rodeghiero F
    Am J Hematol; 2007 May; 82(5):376-80. PubMed ID: 17109387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal recessive von Willebrand disease type 1 or 2 due to homozygous or compound heterozygous mutations in the von Willebrand factor gene. A single center experience on molecular heterogeneity and laboratory features in 12 families.
    Castaman G; Giacomelli S; Rodeghiero F
    Acta Haematol; 2009; 121(2-3):106-10. PubMed ID: 19506356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van Vliet HH
    Acta Haematol; 2009; 121(2-3):85-97. PubMed ID: 19506353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in severe, type III von Willebrand's disease in the Dutch population: candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNA.
    Eikenboom JC; Ploos van Amstel HK; Reitsma PH; Briët E
    Thromb Haemost; 1992 Oct; 68(4):448-54. PubMed ID: 1448779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Q1311X: a novel nonsense mutation of putative ancient origin in the von Willebrand factor gene.
    Casaña P; Martínez F; Haya S; Lorenzo JI; Espinós C; Aznar JA
    Br J Haematol; 2000 Nov; 111(2):552-5. PubMed ID: 11122100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound heterozygosity for two novel mutations (1203insG/Y1456X) in the von Willebrand factor gene causing type 3 von Willebrand disease.
    Xie F; Wang X; Cooper DN; Lan F; Fang Y; Cai X; Wang Z; Wang H
    Haemophilia; 2007 Sep; 13(5):645-8. PubMed ID: 17880457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease.
    Casaña P; Martínez F; Haya S; Tavares A; Aznar JA
    Haematologica; 2001 Apr; 86(4):414-9. PubMed ID: 11325649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A practical approach to genetic testing for von Willebrand disease.
    Pruthi RK
    Mayo Clin Proc; 2006 May; 81(5):679-91. PubMed ID: 16706266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of molecular genetics in diagnosing von Willebrand disease.
    James P; Lillicrap D
    Semin Thromb Hemost; 2008 Sep; 34(6):502-8. PubMed ID: 19085649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic mutations in von Willebrand disease identified by DHPLC and DNA sequence analysis.
    Kakela JK; Friedman KD; Haberichter SL; Buchholz NP; Christopherson PA; Kroner PA; Gill JC; Montgomery RR; Bellissimo DB
    Mol Genet Metab; 2006 Mar; 87(3):262-71. PubMed ID: 16321553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide.
    Hilbert L; Nurden P; Caron C; Nurden AT; Goudemand J; Meyer D; Fressinaud E; Mazurier C;
    Thromb Haemost; 2006 Sep; 96(3):290-4. PubMed ID: 16953269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.